- Hong Kong
- /
- Healthtech
- /
- SEHK:2251
Beijing Airdoc Technology First Half 2024 Earnings: CN¥0.79 loss per share (vs CN¥0.36 loss in 1H 2023)
Beijing Airdoc Technology (HKG:2251) First Half 2024 Results
Key Financial Results
- Revenue: CN¥93.7m (up 14% from 1H 2023).
- Net loss: CN¥80.5m (loss widened by 118% from 1H 2023).
- CN¥0.79 loss per share (further deteriorated from CN¥0.36 loss in 1H 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Beijing Airdoc Technology Earnings Insights
Looking ahead, revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Healthcare Services industry in Hong Kong.
Performance of the Hong Kong Healthcare Services industry.
The company's shares are up 6.3% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. See our latest analysis on Beijing Airdoc Technology's balance sheet health.
Valuation is complex, but we're here to simplify it.
Discover if Beijing Airdoc Technology might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:2251
Beijing Airdoc Technology
Provides artificial intelligence (AI) empowered retina-based early detection, diagnosis, and health risk assessment solutions for medical institutions, consumer healthcare environments, and eye health management settings in Mainland China and internationally.
Flawless balance sheet with high growth potential.